Kevin McEvoy, MD
Urology · Portland, ORNPI 1730176702
Payments from drug & device makers
Across 78 payments — averaging $19.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$221
- Pfizer$142
- Johnson & Johnson$142
- Bayer$137
- Ferring Pharmaceuticals Inc.$112
- AbbVie$106
- plus $629 from 19 others
What the payments were for
- Food & beverage$1,37993%
- Education$1117%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 11 | $221 |
| Pfizer | 9 | $142 |
| Johnson & Johnson | 5 | $142 |
| Bayer | 6 | $137 |
| Ferring Pharmaceuticals Inc. | 6 | $112 |
| AbbVie(2 entities) | 7 | $106 |
| Dendreon Pharmaceuticals LLC | 4 | $87 |
| Antares Pharma, Inc. | 5 | $79 |
| Travere Therapeutics, Inc. | 7 | $65 |
| KCI USA, Inc. | 1 | $52 |
| Endo Pharmaceuticals Inc. | 3 | $37 |
| AstraZeneca | 1 | $31 |
| Veloxis Pharmaceuticals, Inc. | 1 | $30 |
| Kamada Ltd. | 1 | $29 |
| Merck | 1 | $28 |
| 180 Medical, Inc. | 1 | $25 |
| Olympus America Inc. | 1 | $25 |
| Amgen | 1 | $23 |
| Tolmar Pharmaceuticals, Inc. | 1 | $22 |
| Coloplast | 1 | $22 |
| Novartis | 1 | $17 |
| Dornier Medtech America, Inc | 1 | $17 |
| Myriad Genetic Laboratories, Inc. | 1 | $17 |
| Boston Scientific | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $11 |
How this compares
$1,490 in reported general payments places this provider in the 45th percentile of 153 urology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Portland
- Mark GarzottoPortland$2.3M
- Lance MarrPortland$323K
- Ryan KoppPortland$266K
- Jen-Jane LiuPortland$224K
- Sudhir IsharwalPortland$115K
- da David JiangPortland$65K
- Amir PatelPortland$36K
- James TycastPortland$35K
- Ian MetzlerPortland$23K
- Sara Spettel AliyarPortland$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.